Two drinking water systems at U.S. Marine Corps Base Camp Lejeune, North Carolina were contaminated with solvents during 1950s-1985.
We conducted a retrospective cohort mortality study of Marine and Naval personnel who began service during 1975-1985 and were stationed at Camp Lejeune or Camp Pendleton, California during this period. Camp Pendleton’s drinking water was uncontaminated. Mortality follow-up was 1979-2008. Standardized Mortality Ratios were calculated using U.S. mortality rates as reference. We used survival analysis to compare mortality rates between Camp Lejeune (N = 154,932) and Camp Pendleton (N = 154,969) cohorts and assess effects of cumulative exposures to contaminants within the Camp Lejeune cohort. Models estimated monthly contaminant levels at residences. Confidence intervals (CIs) indicated precision of effect estimates.
There were 8,964 and 9,365 deaths respectively, in the Camp Lejeune and Camp Pendleton cohorts. Compared to Camp Pendleton, Camp Lejeune had elevated mortality hazard ratios (HRs) for all cancers (HR = 1.10, 95% CI: 1.00, 1.20), kidney cancer (HR = 1.35, 95% CI: 0.84, 2.16), liver cancer (HR = 1.42, 95% CI: 0.92, 2.20), esophageal cancer (HR = 1.43 95% CI: 0.85, 2.38), cervical cancer (HR = 1.33, 95% CI: 0.24, 7.32), Hodgkin lymphoma (HR = 1.47, 95% CI: 0.71, 3.06), and multiple myeloma (HR = 1.68, 95% CI: 0.76, 3.72). Within the Camp Lejeune cohort, monotonic categorical cumulative exposure trends were observed for kidney cancer and total contaminants (HR, high cumulative exposure = 1.54, 95% CI: 0.63, 3.75; log10 β = 0.06, 95% CI: -0.05, 0.17), Hodgkin lymphoma and trichloroethylene (HR, high cumulative exposure = 1.97, 95% CI: 0.55, 7.03; β = 0.00005, 95% CI: -0.00003, 0.00013) and benzene (HR, high cumulative exposure = 1.94, 95% CI: 0.54, 6.95; β = 0.00203, 95% CI: -0.00339, 0.00745). Amyotrophic Lateral Sclerosis (ALS) had HR = 2.21 (95% CI: 0.71, 6.86) at high cumulative vinyl chloride exposure but a non-monotonic exposure-response relationship (β = 0.0011, 95% CI: 0.0002, 0.0020).
The study found elevated HRs at Camp Lejeune for several causes of death including cancers of the kidney, liver, esophagus, cervix, multiple myeloma, Hodgkin lymphoma and ALS. CIs were wide for most HRs. Because <6% of the cohort had died, long-term follow-up would be necessary to comprehensively assess effects of drinking water exposures at the base.
Samples taken during 1980-1985 at United States Marine Corps (USMC) Base Camp Lejeune, North Carolina detected solvents in drinking water supplied by two of the base’s eight treatment plants, Tarawa Terrace (TT) and Hadnot Point (HP). The TT supply wells were contaminated by an off-base dry cleaning business. The HP supply wells were contaminated by on-base sources: leaking underground storage tanks, industrial area spills and waste disposal sites. Contaminated supply wells in the TT and HP systems were shut down by February 1985 [
The primary contaminant in the TT distribution system was tetrachloroethylene (PCE) with a maximum measured level of 215 micrograms per liter (μg/L). Also detected were much lower levels of trichloroethylene (TCE), trans-1,2-dichloroethylene, and vinyl chloride, created when PCE degraded in ground water over time. The TT system served approximately 1,850 family housing units on base during 1975-1985 [
The primary contaminant in the HP distribution system was TCE with a maximum detected level of 1,400 μg/L. The maximum level of PCE was 100 μg/L, and benzene was also detected. Trans-1,2-dichloroethylene and vinyl chloride were present due to degradation of TCE in ground water [
The Holcomb Boulevard system was a third system at the base, which served approximately 2,100 family housing units and was uncontaminated except for intermittent periods during dry spring-summer months when the HP system provided supplementary water. During a 2-week period in early 1985, the Holcomb Boulevard treatment plant shut down for repairs and the HP system provided water for its service area.
In each system, water from supply wells was mixed together at the treatment plant prior to distribution. Contamination levels in each system varied depending on the wells in use at a particular time.
Current U.S. maximum contaminant levels (MCLs) for TCE, PCE and benzene are 5 μg/L. The MCL for vinyl chloride is 2 μg/L. TCE has recently been classified as a human carcinogen [
Several meta-analyses and reviews assessed health effects of these chemicals [
The literature is limited on health effects of drinking water exposures to these chemicals. A drinking water study in NJ observed associations between TCE and leukemia and non-Hodgkin lymphoma (NHL), and PCE and NHL [
The purpose of this study was to determine whether exposures of Marine and Naval personnel to contaminated drinking water at Camp Lejeune increased risk of mortality from cancers and other chronic diseases.
We identified several diseases of
Diseases of
Because this was a data linkage study with no smoking information, we evaluated smoking-related diseases not known to be associated with the contaminants to assess possible confounding: cardiovascular disease, chronic obstructive pulmonary disease (COPD), and stomach cancer.
The Camp Lejeune cohort consisted of 154,932 Marine and Naval personnel (“Marines”) who began active duty service during April 1975 – December 1985 and were stationed at Camp Lejeune anytime during this period. A comparison cohort consisted of 154,969 Marine and Naval personnel who began active duty service during April 1975 – December 1985, were stationed anytime during this period at USMC Base Camp Pendleton, but were not stationed at Camp Lejeune during this period. Camp Pendleton, located along the Southern California coast in northern San Diego County and southern Orange County, did not have contaminated drinking water during the period when the cohort was stationed at the base [
We obtained data for Camp Lejeune and Camp Pendleton from Defense Manpower Data Center (DMDC) Active Duty Military Personnel Master File for April 1975-December 1985. Unit information first became available in the DMDC file in April 1975 [
Personal identifier information from the DMDC database was matched to data in the Social Security Administration (SSA) Death Master File (DMF) and SSA Office of Research, Evaluation and Statistics (ORES) Presumed Living Search to determine vital status [
Due to limited numbers of historical samples for drinking water contamination, ATSDR conducted a historical reconstruction of the contamination using ground water fate and transport and distribution system models. Monthly average estimates of contaminant concentrations in each system were computed and reported in peer-reviewed agency reports [
Estimated monthly average contaminant concentrations in the Tarawa Terrace system, 1975 – 1985
| Tetrachloroethylene | 75.7 | 84.9 | 0 – 158.1 | 117 | 16 |
| Trichloroethylene | 3.1 | 3.5 | 0 – 6.6 | 11 | 0 |
| Vinyl chloride | 5.6 | 6.2 | 0 – 12.3 | 117 | 0 |
| Tetrachloroethylene | 68.3 | 68.2 | 43.8 – 94.8 | 60 | 0 |
| Trichloroethylene | 2.8 | 2.9 | 1.7 – 3.9 | 0 | 0 |
| Vinyl chloride | 5.2 | 5.5 | 2.6 – 7.3 | 60 | 0 |
| Tetrachloroethylene | 96.1 | 95.5 | 0¥ – 158.1 | 57 | 16 |
| Trichloroethylene | 3.9 | 3.9 | 0¥ – 6.6 | 11 | 0 |
| Vinyl chloride | 7.0 | 7.0 | 0¥ – 12.3 | 57 | 0 |
*Two contaminated wells were shut down in January 1985. Estimated monthly average tetrachloroethylene levels from February through December 1985 were <4 μg/L.
¥One contaminated well was shut down for maintenance during 7/80 – 8/80 and 1/83 – 2/83. The other contaminated well was not in use until August 1984.
Estimated monthly average contaminant concentrations in the Hadnot Point system, 1975 – 1985
| Tetrachloroethylene | 15.7 | 15.4 | 0 – 38.7 | 111 | 0 |
| Trichloroethylene | 358.7 | 365.9 | 0 – 783.3 | 122 | 113 |
| Vinyl chloride | 24.0 | 22.2 | 0 – 67.3 | 122 | 0 |
| Benzene | 5.4 | 4.6 | 0 – 12.2 | 63 | 0 |
| Tetrachloroethylene | 12.2 | 12.0 | 1.4 – 24.1 | 53 | 0 |
| Trichloroethylene | 325.1 | 327.7 | 60.6 – 546.3 | 60 | 55 |
| Vinyl chloride | 17.3 | 16.5 | 2.3 – 33.4 | 60 | 0 |
| Benzene | 3.5 | 3.4 | 0 – 5.8 | 4 | 0 |
| Tetrachloroethylene | 21.5 | 21.4 | 2.2 – 38.7 | 58 | 0 |
| Trichloroethylene | 449.2 | 446.2 | 42.6 – 783.3 | 62 | 58 |
| Vinyl chloride | 34.3 | 35.7 | 4.2 – 67.3 | 62 | 0 |
| Benzene | 7.6 | 7.6 | 1.6 – 12.2 | 59 | 0 |
*Contaminated wells were shut down after February 1985. From March through December 1985, estimated monthly average levels of trichloroethylene, tetrachloroethylene and vinyl chloride were <1 μg/L, and benzene was <4 μg/L.
On average, an individual in the Camp Lejeune cohort resided at the base for 18 months. Each individual was assigned estimated monthly average contaminant concentrations in the drinking water system serving the individual’s residence during the period of residence. We used several sources of information to determine an individual’s residence (Figure
Married Camp Lejeune cohort members resided either in base family housing or in off-base housing. We used probability and manual matching to link married cohort members to base family housing records on name, rank, occupancy dates, and dates stationed on base.
Unmarried officers resided in bachelor officers’ quarters served by the Holcomb Boulevard water system during 1975-1985. Unmarried enlisted individuals resided in barracks. Unit barrack locations were identified using information provided by retired marines, base staff, and base command chronologies. Female marines resided in areas served by the HP system until June 1977 when they moved to an area with uncontaminated drinking water.
Follow-up began on January 1, 1979 or start of active duty service at either base, whichever was later, and continued until December 31, 2008, if the person was known to be alive, or to date of death. Those with unknown vital status were followed until the last date they were known to be alive based on available data.
We used the Life Table Analysis System (LTAS) to compute cause-specific, standardized mortality ratios (SMRs) and 95% confidence intervals (CIs) comparing the Camp Lejeune and Camp Pendleton cohorts to age- sex- race-and calendar period-specific U.S. mortality rates for underlying and contributing causes of death [
a. Comparisons between Camp Lejeune and Camp Pendleton cohorts
We used Cox extended regression models [
We accounted for a “latency period” by lagging exposure to a base by 10, 15, and 20 years in addition to an analysis with no lag. For example, a 10 year lag would assign to an individual aged 29, the base the individual was stationed at age 19. If this individual was not yet serving at age 19, then the person-year for age 29 was assigned to a category, “not at either base”. We used the Akaike’s information criterion (AIC), a measure of model goodness of fit, to select an appropriate lag period.
b. Analyses within the Camp Lejeune cohort
Within the Camp Lejeune cohort, we evaluated exposure-response relationships between cumulative exposures to drinking water contaminants and cause of mortality using Cox extended regression models with age as the time variable and cumulative exposure as a time-varying variable. Estimated monthly average contaminant concentrations in the water system serving the individual’s residence and occupancy dates were used to calculate cumulative exposures (“μg/L-months”) to each contaminant and to the total amount of these contaminants (“TVOC”).
We evaluated untransformed and log10 transformed cumulative exposures as continuous variables. The log transform is appropriate when exposure-response relationships plateau or attenuate at higher levels of exposure [
We also evaluated cumulative exposure as categorical variable (no, low, medium, and high exposure) based on cumulative exposure distributions of each contaminant among those exposed cohort members who died of any cancer. The low to high exposure categories contained approximately equal numbers of exposed cancer deaths in order to produce similar variances for hazard ratios across exposure categories [
We evaluated PCE, TCE, vinyl chloride, and benzene separately because the contaminants were highly correlated and could not be included together in a model. For example, correlations ≥ .96 were observed between cumulative exposures to TCE, VC, and benzene because the Hadnot Point system was the source of higher levels of these contaminants. Lower correlations ranging from .44 to .53 were observed between PCE and the other contaminants because the Tarawa Terrace system had high levels of PCE but low levels of other contaminants. Because of the high correlations among the contaminants, it is not possible to separate the effects of each of the individual contaminants, although TCE and PCE levels were substantially higher than the levels of the other contaminants. In order to evaluate the contaminants as a group, we created the variable, TVOC, by combining PCE, TCE, trans-1,2-dichloroethylene, vinyl chloride and benzene.
To account for latency, we evaluated 10, 15, and 20 year lag periods for cumulative exposures in addition to a “no lag” period.
The use of either categorical or continuous exposure variables (whether transformed or not) imposes a structure on the exposure-response relationship which may be inaccurate [
In subsequent analyses, we evaluated duration at Camp Lejeune and duration exposed to the contaminated drinking water as time-varying categorical variables, and average exposures as time-independent categorical and continuous variables.
c. Confounder assessment
DMDC and NDI data were available for sex, race, marital status, birth cohort, date of death, age at death, rank, education, and duty occupation. For confounding to occur, a risk factor must be associated with the exposure as well as with the disease of interest. To identify potential confounding, we used a “10% change in the estimate” rule [
Information on smoking, alcohol consumption, and occupational history prior to or after active duty service, was unavailable. We evaluated possible smoking confounding by subtracting the log HR among smoking-related diseases from the log HR of the disease of interest [
Because the cohorts began active duty service after 1974, none were Vietnam veterans. However, information was unavailable concerning service in later wars involving hazardous exposures.
d. Interpretation of findings
Interpretation of study findings was based on the magnitude of the adjusted SMR or HR. For analyses internal to the Camp Lejeune cohort, we also based our interpretation on the exposure-response relationship, giving more emphasis to monotonic trends in the categorical cumulative exposure variables. A monotonic trend occurs when every change in the HR with increasing category of exposure is in the same direction, although the trend could have flat segments but never reverse direction [
We computed 95% confidence intervals to show the precision of the HR and regression coefficient estimates, and we included p-values for information purposes only. We did not use statistical significance testing to interpret findings [
The cohorts had similar demographics and most were under age 55 by the end of follow-up (Table
Demographics of the Camp Lejeune and Camp Pendleton cohorts
| Male | 94.8% | 96.4% |
| Female | 5.2% | 3.6% |
| “White” | 73.1% | 77.6% |
| African American | 24.2% | 17.0% |
| “other” or unknown | 2.7% | 5.4% |
| Median age, start of follow-up | 20 | 20 |
| Median age, end of follow-up | 49 | 49 |
| % ≥55 yrs, end of follow-up | 2.7% | 3.2% |
| Not a high school graduate | 11.3% | 14.7% |
| High school graduate | 84.9% | 80.5% |
| College graduate | 3.8% | 4.8% |
| Enlisted | 96.4% | 95.5% |
| Officer | 3.6% | 4.5% |
| Median months active duty service | 36 | 35 |
| Total deaths | 8,964 (5.8%) | 9,365 (6.0%) |
| % deaths occurring >1995 | 55.5% | 54.7% |
| Total lost to follow-up | 1,990 (1.3%) | 2,339 (1.5%) |
| Total person-years of follow-up | 4.14 million | 4.19 million |
Because we observed similar results for contributing and underlying causes of death, only results for underlying cause of death are presented. Over a quarter of deaths in both cohorts were due to cancers and cardiovascular diseases combined (Table
Standardized mortality ratios (SMRs), underlying cause of death
| Cause of death | Obs. | Exp. | SMR (95% CI) | Obs. | Exp. | SMR (95% CI) |
| All causes | 9,365 | 10,922 | 0.86 (0.84, 0.87) | 8,964 | 10,864 | 0.83 (0.81, 0.84) |
| All cancers | 1,008 | 1,296 | 0.78 (0.73, 0.83) | 1,078 | 1,272 | 0.85 (0.80, 0.90) |
| Diseases of primary interest | ||||||
| Kidney cancer | 33 | 37.20 | 0.89 (0.61, 1.25) | 42 | 36.08 | 1.16 (0.84, 1.57) |
| Bladder cancer | 14 | 13.65 | 1.03 (0.56, 1.72) | 11 | 13.04 | 0.84 (0.42, 1.51) |
| Liver* cancer | 39 | 69.21 | 0.56 (0.40, 0.77) | 51 | 69.20 | 0.74 (0.55, 0.97) |
| Esophageal cancer | 27 | 43.33 | 0.62 (0.41, 0.91) | 35 | 41.34 | 0.85 (0.59, 1.18) |
| Hematopoietic cancers | 167 | 215.93 | 0.77 (0.66, 0.90) | 165 | 211.10 | 0.78 (0.67, 0.91) |
| Hodgkin | 23 | 25.86 | 0.89 (0.56, 1.33) | 24 | 25.03 | 0.96 (0.61, 1.43) |
| NHL** | 68 | 87.56 | 0.78 (0.60, 0.98) | 58 | 85.50 | 0.68 (0.52, 0.88) |
| Multiple myeloma | 12 | 16.26 | 0.74 (0.38, 1.29) | 17 | 16.13 | 1.05 (0.61, 1.69) |
| Leukemias | 64 | 86.26 | 0.74 (0.57, 0.95) | 66 | 84.43 | 0.78 (0.60, 0.99) |
| Cervical cancer | 2 | 3.53 | 0.57 (0.07, 2.05) | 5 | 4.88 | 1.03 (0.33, 2.39) |
| Pancreatic cancer | 44 | 60.05 | 0.73 (0.53, 0.98) | 57 | 58.29 | 0.98 (0.74, 1.27) |
| Colon cancer | 73 | 93.28 | 0.78 (0.61, 0.98) | 86 | 92.29 | 0.93 (0.75, 1.15) |
| Rectal cancer | 16 | 29.84 | 0.54 (0.31, 0.87) | 24 | 29.54 | 0.81 (0.52, 1.21) |
| Soft tissue cancers | 21 | 27.82 | 0.75 (0.47, 1.15) | 29 | 27.44 | 1.06 (0.71, 1.52) |
| Brain cancer | 80 | 93.36 | 0.86 (0.68, 1.07) | 74 | 88.95 | 0.83 (0.65, 1.04) |
| Laryngeal cancer | 13 | 12.15 | 1.07 (0.57, 1.83) | 6 | 11.92 | 0.50 (0.18, 1.10) |
| Lung*** cancer | 216 | 265.44 | 0.81 (0.71, 0.93) | 237 | 259.01 | 0.92 (0.80, 1.04) |
| Oral cancers**** | 35 | 37.64 | 0.93 (0.65, 1.29) | 26 | 37.38 | 0.70 (0.45, 1.02) |
| Breast (female) cancer | 7 | 14.68 | 0.48 (0.19, 0.98) | 10 | 19.62 | 0.51 (0.24, 0.94) |
| Prostate cancer | 15 | 10.68 | 1.41 (0.79, 2.32) | 18 | 10.41 | 1.73 (1.02, 2.73) |
| Liver diseases | 233 | 322.70 | 0.72 (0.63, 0.82) | 191 | 311.90 | 0.61 (0.53, 0.71) |
| Kidney diseases | 37 | 71.72 | 0.52 (0.37, 0.71) | 37 | 74.54 | 0.50 (0.35, 0.68) |
| ALS | 27 | 19.42 | 1.39 (0.92, 2.02) | 21 | 18.45 | 1.14 (0.70, 1.74) |
| Multiple sclerosis | 10 | 14.95 | 0.67 (0.32, 1.23) | 12 | 14.75 | 0.81 (0.42, 1.42) |
| Stomach cancer | 29 | 41.43 | 0.70 (0.47, 1.01) | 35 | 41.88 | 0.84 (0.58, 1.16) |
| Cardiovascular disease† | 1,376 | 1,791 | 0.77 (0.73, 0.81) | 1,390 | 1,781 | 0.78 (0.74, 0.82) |
| COPD | 45 | 55.82 | 0.81 (0.59, 1.08) | 47 | 53.89 | 0.87 (0.64, 1.16) |
Not evaluated due to small numbers were Parkinson’s disease and male breast cancer.
*Biliary passages, liver and gall bladder **Non-Hodgkin lymphoma.
***Trachea, bronchus, and lung ****Oral cavity and Pharynx.
†Includes diseases of the heart and other diseases of the circulatory system.
Camp Lejeune = 154,932; person-years = 4,140,042.
Camp Pendleton = 154,969; person-years = 4,190,132.
Comparing each cohort to U.S. mortality rates, most SMRs were less than 1.00 indicating a “healthy veteran effect” [
Table
Camp Lejeune vs Camp Pendleton: hazard ratios and 95% confidence intervals, adjusted by sex, race, rank and education, 10-year lag
| All cancers | 1.10 | 0.02 | ||
| Kidney cancer | 1.35 | 0.19 | ||
| Bladder cancer | 0.76 | 0.50 | ||
| Liver* cancer | 1.42 | 0.11 | ||
| Esophageal cancer | 1.43 | 0.17 | ||
| Hematopoietic cancers | 1.05 | 0.57 | ||
| Hodgkin | 1.47 | 0.26 | ||
| NHL** | 0.81 | 0.43 | ||
| Multiple myeloma | 1.68 | 0.21 | ||
| Leukemias | 1.11 | 0.63 | ||
| Cervical cancer | 1.33 | 0.74 | ||
| Pancreatic cancer | 1.36 | 0.13 | ||
| Colorectal cancers | 1.13 | 0.35 | ||
| Colon cancer | 1.04 | 0.76 | ||
| Rectal cancer | 1.60 | 0.15 | ||
| Soft tissue cancers | 1.38 | 0.30 | ||
| Brain cancer | 0.93 | 0.84 | ||
| Laryngeal cancer | 0.54 | 0.22 | ||
| Lung*** cancer | 1.16 | 0.10 | ||
| Oral cancers**** | 0.82 | 0.46 | ||
| Breast (female) cancer | 0.93 | 0.88 | ||
| Prostate cancer | 1.23 | 0.57 | ||
| Liver diseases | 0.87 | 0.18 | ||
| Kidney diseases | 1.00 | 0.95 | ||
| ALS | 0.83 | 0.54 | ||
| Multiple sclerosis | 1.21 | 0.65 | ||
| Stomach cancer | 1.15 | 0.58 | ||
| Cardiovascular disease† | 1.04 | 0.31 | ||
| COPD | 1.08 | 0.70 | ||
Not evaluated due to small numbers were Parkinson’s disease, male breast cancer, and aplastic anemia.
LCL: lower confidence limit UCL: upper confidence limit.
*Biliary passages, liver and gall bladder ***Trachea, bronchus, and lung.
****Oral cavity and Pharynx.
†Includes heart diseases and other diseases of the circulatory system.
An evaluation of leukemia subtypes was not conducted because a considerable percentage (22.7%) of the leukemias were classified as “acute leukemia, not otherwise specified” in the Camp Lejeune cohort compared to the percentage (9.4%) occurring in the Camp Pendleton cohort.
We conducted additional analyses to determine whether the elevated HRs for the Camp Lejeune cohort could be explained by cumulative exposures to the contaminants or by some other factor. For these analyses, the Camp Pendleton cohort was the reference group and the Camp Lejeune cohort was split into two groupings: no/low cumulative exposure and medium/high cumulative exposure (Additional file
Of diseases of secondary interest, Camp Lejeune had elevated HRs for colorectal cancers, in particular, rectal cancer (HR = 1.60, 95% CI: 0.83, 3.07), pancreatic cancer (HR = 1.36, 95% CI: 0.91, 2.02), soft tissue cancers (HR = 1.38, 95% CI: 0.73, 2.64), lung cancer (HR = 1.16, 95% CI: 0.96, 1.40), prostate cancer (HR = 1.23, 95% CI: 0.60, 2.49), and multiple sclerosis (HR = 1.21, 95% CI: 0.50, 2.94). Diseases with HRs ≤ 1.00 were ALS, liver diseases, kidney diseases and brain, laryngeal and oral cancers.
The elevation in the HR for lung cancer was due entirely to those with higher cumulative exposures at Camp Lejeune (Additional file
The highest HR among smoking-related diseases was for stomach cancer (HR = 1.15, 95% CI: 0.70, 1.90). Using the stomach cancer result to adjust for smoking confounding would reduce the HRs for diseases of primary and secondary interest by 13%. However, HRs for the other smoking-related diseases (COPD and cardiovascular disease) were less than 1.10, and HRs for diseases that are both smoking and solvent related (e.g., laryngeal and oral cancers) were less than 1.00. Therefore it is likely that the confounding effects of smoking are less than 10% for the comparisons between Camp Lejeune and Camp Pendleton.
Categorizations of cumulative exposure (“μg/L –months”) for each contaminant are presented in Table
Categorization of cumulative exposure variables (μg/L –months) within the Camp Lejeune cohort
| ≤ 1 | >1 - 155 | >155 - 380 | >380 – 8,585 | |
| 66, 582 (43.0%) | 28,230 (18.2%) | 27,255 (17.6%) | 32,865 (21.2%) | |
| ≤ 1 | >1 – 3,100 | >3,100 – 7,700 | >7,700 – 39,745 | |
| 64, 584 (41.7%) | 31,069 (20.1%) | 27,638 (17.8%) | 31,641 (20.4%) | |
| ≤ 1 | >1 - 205 | >205 - 500 | >500 – 2,800 | |
| 66, 470 (42.9%) | 27,651 (17.8%) | 28,063 (18.1%) | 32,748 (21.1%) | |
| < 2 | 2 - 45 | >45 - 110 | >110 - 601 | |
| 64, 580 (41.7%) | 24,579 (15.9%) | 31,838 (20.5%) | 33,935 (21.9%) | |
| ≤ 1 | >1 – 4,600 | >4,600 – 12,250 | >12,250 - 64,016 | |
| 57, 328 (37.0%) | 35,432 (22.9%) | 29,687 (19.2%) | 32,485 (21.0%) | |
*An individual’s maximum amount of cumulative exposure (μg/L –months
N = 154,932.
We observed a monotonic exposure-response relationship for kidney cancer and the categorized cumulative exposure variable for TVOC (HR for high exposure category = 1.54, 95% CI: 0.63, 3.75) (Table
Hazard ratios (95% CI) for categorical cumulative exposure, and coefficients (95% CI) for continuous cumulative exposure
| PCE | 1.40 (0.54, 3.58) N=8 | 1.82 (0.75, 4.42) N=11 | 1.59 (0.66, 3.86) N=11 | .00009 (-0.00048, 0.00065), p=.76 | .0813 (-0.0553, 0.2179), p=.24 |
| TVOC | 1.42 (0.58, 3.47) N=10 | 1.44 (0.58, 3.59) N=10 | 1.54 (0.63, 3.75) N=11 | .00001 (-0.00003, 0.00005) p=.59 | .0633 (-0.0481, 0.1747) p=.26 |
| TCE | 1.52 (0.42, 5.59) N=4 | 1.63 (0.43, 6.12) N=4 | 1.97 (0.55, 7.03) N=5 | .00005 (-0.00003, 0.00013) p=.20 | .0940 (-0.0650, 0.2530) p=.25 |
| VC | 1.20 (0.29, 4.94) N=3 | 2.07 (0.59, 7.27) N=5 | 1.99 (0.56, 7.13) N=5 | .00056 (-0.00060, 0.00172) p=.34 | .1101 (-0.0817, 0.3019) p=.26 |
| Benzene | 1.24 (0.30, 5.11) N=3 | 1.88 (0.54, 6.61) N=5 | 1.94 (0.54, 6.95) N=5 | .00203 (-0.00339, 0.00745) p=.46 | .1074 (-0.1088, 0.3236) p=.33 |
| TVOC | 0.66 (0.13, 3.39) N=2 | 1.77 (0.50, 6.25) N=5 | 2.17 (0.63, 7.50) N=6 | .00003 (-0.00003, 0.00009) p=.24 | .0752 (-0.0818, 0.2322) p=.35 |
| TCE | 2.00 (1.00, 4.00) N=16 | 1.54 (0.71, 3.36) N=11 | 1.81 (0.85, 3.85) N=13 | .00002 (-0.00004, 0.00008) p=.46 | .0801 (-0.0093, 0.1695) p=.08 |
| Benzene | 2.54 (1.27, 5.08) N=17 | 1.46 (0.66, 3.20) N=11 | 1.69 (0.77, 3.67) N=12 | .00168 (-0.00158, 0.00494) p=.31 | .1276 (0.0020, 0.2532) p=.05 |
| TVOC | 2.50 (1.24, 5.03) N=19 | 1.33 (0.56, 3.14) N=9 | 2.33 (1.08, 5.03) N=15 | .00001 (-0.00003, 0.00005) p=.44 | .0950 (0.0032, 0.1868) p=.04 |
| TCE | 0.91 (0.25, 3.23) N=4 | 0.87 (0.21, 3.57) N=3 | 1.93 (0.65, 5.79) N=8 | .00007 (0.00001, 0.00013) p=.04 | .0436 (-0.1083, 0.1955) p=.57 |
| PCE | 0.69 (0.13, 3.55) N=2 | 1.58 (0.45, 5.50) N=5 | 1.96 (0.64, 6.02) N=8 | .00039 (-0.00002, 0.00080) p=.06 | .0836 (-0.1060, 0.2732) p=.39 |
| VC | 1.22 (0.33, 4.51) N=4 | 0.91 (0.22, 3.87) N=3 | 2.21 (0.71, 6.86) N=8 | .00110 (0.00020, 0.00200) p=.02 | .0724 (-0.1149, 0.2597) p=.45 |
| TVOC | 1.27 (0.37, 4.41) N=5 | 0.89 (0.21, 3.82) N=3 | 2.11 (0.67, 6.68) N=8 | .00005 (0.00001, 0.00009) p=.03 | .0702 (-0.0872, 0.2276) p=.38 |
The referent group for each contaminant consists of those Camp Lejeune cohort members with cumulative exposures within the reference level for that contaminant shown in Table
Exposure lagged 10 years. Adjusted for race, sex, rank and education. Selected causes of death. Camp Lejeune cohort (N = 154,932).
We observed monotonic exposure-response relationships for Hodgkin lymphoma and TCE and benzene with HRs at the high exposure category of 1.97 (95% CI: 0.55, 7.03) and 1.94 (95% CI: 0.54, 6.95), respectively (Table
Non-monotonic exposure-response relationships were observed for leukemias, with HRs for the high exposure category of 2.33 (95% CI: 1.08, 5.03), 1.81 (95% CI: 0.85, 3.85) and 1.69 (95% CI: 0.77, 3.67) for TVOC, TCE, and benzene, respectively (Table
Two other diseases of primary interest had HRs above 1.00 in the high exposure category but trends were non-monotonic: NHL had HRs between 1.10 and 1.20 for TVOC, TCE, vinyl chloride and PCE, and bladder cancer had an HR of 2.26 for benzene based on 3 cases, and HRs of 1.20 for TVOC and PCE (see Additional file
Of diseases of secondary interest, ALS had HRs > 1.90 in the high cumulative exposure category for TVOC (HR = 2.11, 95% CI: 0.67, 6.68), TCE (HR = 1.93, 95% CI: 0.65, 5.79), PCE (HR = 1.96, 95% CI: 0.64, 6.02), and vinyl chloride (HR = 2.21, 95% CI: 0.71, 6.86) but the exposure-response trends were not monotonic (Table
We did not observe monotonic exposure-response trends for other diseases of secondary interest. The HR for PCE in the high exposure category and oral cancers was 1.80 (95% CI: 0.59, 5.46), but this was slightly lower than the HR at the low exposure category (HR = 1.89, 95% CI: 0.63, 5.66) and the middle exposure category had an HR < 1.00 (see Additional file
Except for benzene, we observed monotonic exposure-response relationships for the categorized cumulative exposure variables and cardiovascular disease, with HRs ≤ 1.12 in the high exposure categories. For stomach cancer and PCE, a non-monotonic relationship was observed with HR = 1.56 (95% CI: 0.66, 3.69) at the high exposure category. The HRs for COPD were <1.00 for the middle and high cumulative exposure categories of the contaminants (see Additional file
Analyses of duration of exposure and average exposure produced results similar to cumulative exposure and are not presented.
The diseases of primary and secondary interest under evaluation were selected based primarily on evidence from occupational studies of solvents such as TCE. Although occupational exposures occur primarily via inhalation and levels are generally much higher than drinking water exposures, the levels of TCE in the Hadnot Point distribution system were sufficiently high to result in exposures comparable to those that may occur in some occupational settings.
For example, daily inhalation exposures to TCE between 2.2 mg/day and 9.5 mg/day could occur in occupational settings where personal monitoring measurements indicated TCE air concentrations between 1.2 and 5.1 parts per million (ppm) [
One estimate of mean TCE air concentrations across all industries from the 1950s through the 1980s was 38 parts per million (ppm) [
In the comparison between Camp Lejeune and Camp Pendleton, the HRs for several cancers of primary interest were elevated in the Camp Lejeune cohort. Of these cancers, the elevated HRs for kidney cancer, cervical cancer, leukemias and Hodgkin lymphoma occurred primarily or exclusively among those with higher cumulative exposures. The HRs for several diseases of secondary interest were also elevated. Of these diseases, the elevated HR for lung cancer occurred exclusively among those with higher cumulative exposures.
In analyses internal to the Camp Lejeune cohort, we observed monotonic trends for cumulative exposure to one or more contaminant and kidney cancer and Hodgkin lymphoma. For ALS, HRs > 1.90 were observed in the high exposure category for all the contaminants except benzene.
Drinking water studies conducted at Cape Cod, MA found associations between PCE and several cancers: lung, bladder, rectal, leukemia, and female breast [
Camp Pendleton did not have contaminated drinking water, but similar to Camp Lejeune, there were NPL sites located on the base. Although a public health assessment conducted by ATSDR at Camp Pendleton found “no apparent public health hazard” from these toxic waste sites [
By the end of the study, there was one death in the Camp Lejeune cohort whose underlying cause was male breast cancer. However, many cases of male breast cancer among those who resided at Camp Lejeune have been identified in media reports and by diligent work conducted by members of the exposed population. Because male breast cancer has a relatively high survival rate, ATSDR collected data from the Veterans Affairs’s cancer registry and is currently evaluating the data regarding conducting a case-control study of male breast cancer incidence.
We conducted comparisons between Camp Lejeune and Camp Pendleton to minimize the bias due to the healthy veteran effect and because of concern that everyone at Camp Lejeune was exposed to contaminated drinking water during daily activities if not at the residence. The Camp Pendleton cohort was an appropriate comparison population. Demographics and the healthy veteran effect were similar in both cohorts. The only major difference was drinking water contamination at Camp Lejeune.
The study had several strengths including large cohorts, small percentage of loss to follow-up, and rigorous reconstruction of historical levels of drinking water contamination. However, there were several limitations. The average residence at Camp Lejeune was about 19 months (standard deviation = 13 months, range: 3-102 months). Many had short exposure durations that likely reduced the magnitude of the effects observed and made interpretation difficult.
A serious limitation was exposure misclassification, likely non-differential since exposure assignments should be unrelated to disease status. Such misclassification could bias HRs in comparisons between Camp Lejeune (“exposed”) and Camp Pendleton (“unexposed”) toward the null value of 1.0, resulting in underestimates of true effects of exposure. In analyses within the Camp Lejeune cohort, such bias could distort exposure-response relationships, e.g., producing non-monotonic trends that attenuate or turn negative at high exposure levels [
There were several sources of exposure misclassification. First, because historical research was necessary to identify units stationed at each base, errors in base assignment likely occurred. Second, determining a unit’s barrack location at Camp Lejeune was based primarily on recollections of retired marines. Third, family housing data inaccuracies hindered matching of married individuals to base housing, so some may have been wrongly assigned as living off-base and unexposed. Fourth, many stationed at Camp Lejeune spent time away from the base for training or deployment.
For the comparisons between the Camp Lejeune and Camp Pendleton cohorts, it is likely that the sensitivity of the exposure classification would be very high (e.g., >0.95) and the false-negative proportion would be very low because very few of those classified as “unexposed” (i.e., the Camp Pendleton cohort) would have an exposure to these contaminants. On the other hand, the specificity of the exposure classification would be much lower (e.g., between 0.70 and 0.85) because all members of the Camp Lejeune cohort were considered “exposed” although it is likely that some were not exposed. To apply a method to correct for non-differential exposure misclassification bias [
Disease misclassification bias (both false positives and false negatives) is also a possibility. For example, some cancers of the digestive system and oral cavity/pharynx appear to be underreported on death certificates compared to cancer registry data, whereas cancers of the esophagus, lung, liver and brain may be over reported compared to cancer registry data [
Another limitation was lack of information on smoking and other risk factors. Such risk factors, if associated with exposure status, could be confounders, biasing HRs in either direction and distorting exposure-response relationships. However, both bases had similar demographics so it is unlikely that confounding was a major source of bias in comparisons between the two bases. It is also unlikely that unmeasured risk factors would be associated with contaminant cumulative exposure levels.
We evaluated smoking-related diseases not known to be associated with solvent exposure to evaluate possible confounding by smoking. In comparisons between the two cohorts, we observed an HR of 1.15 for stomach cancer suggesting that the confounding effect of smoking would be no more than 13% and within the range observed in occupational studies [
For the comparisons of cumulative exposure within Camp Lejeune, there is mixed evidence of confounding by smoking. For example, the HRs for oral cancers and stomach cancer are between 1.4 and 1.8 which would indicate the potential for considerable confounding by smoking. On the other hand, the HRs for COPD, esophageal cancer, and pancreatic cancer are all less than 1.00 indicating no confounding by smoking, and the results for lung cancer, bladder cancer and cardiovascular disease (i.e., HRs between 1.10 and 1.20) indicate that confounding by smoking would be no more than 15%. Given these results, the cumulative exposure comparisons within the Camp Lejeune cohort should be minimally affected by confounding due to smoking.
Many HR estimates lacked precision, as indicated by wide confidence intervals, due to small numbers of specific causes of death. Lack of precision in the HR estimates indicates uncertainty about the actual magnitude of the effects of the drinking water exposures on specific causes of death. Despite the large sizes of the cohorts, there were relatively small numbers of specific causes of death due to the healthy veteran effect and because most people in the cohort were younger than 55 at the end of follow-up.
The study found elevated HRs in the Camp Lejeune cohort for several causes of mortality including kidney cancer, liver cancer, esophageal cancer, cervical cancer, multiple myeloma, Hodgkin lymphoma, and ALS. However, the precision of many HR estimates was low as indicated by wide confidence intervals. Approximately 97% of the Camp Lejeune cohort was under the age of 55 and less than 6% had died by the end of the study. Long-term follow-up would be necessary for a comprehensive assessment of the effects of exposures to the contaminated drinking water at the base.
ATSDR: Agency for toxic substances and disease registry; AIC: Akaike’s information criterion; ALS: Amyotrophic lateral sclerosis; COPD: Chronic obstructive pulmonary disease; CI: Confidence interval; DMF: Death master file; DMDC: Defense manpower data center; HP: Hadnot point; HR: Hazard ratio; ICD: International classification of diseases; LTAS: Life table analysis system; MCL: Maximum contaminant level; μg/L: Micrograms per liter; mg/day: Milligrams per day; MS: Multiple sclerosis; NDI: National death index; NHL: Non-Hodgkin lymphoma; NTP: National toxicology program; ORES: Office of research, evaluation and statistics; ppm: Parts per million; RCS: Restricted cubic spline functions; SSN: Social Security number; SSA: Social Security Administration; SMR: Standardized mortality ratio; TT: Tarawa Terrace; TVOC: Total amount of the contaminants; TCE: Trichloroethylene; PCE: Tetrachloroethylene or perchloroethylene; USMC: United States Marine Corps; EPA: United States Environmental Protection Agency.
All authors declare they have no actual or potential competing financial interest.
FJB participated in the study design, data collection, analysis and interpretation of data, and drafted the manuscript. PZR participated in the study design, data collection, interpretation of data, and helped draft the manuscript. MM conducted the water modeling. TCL assisted with analysis and interpretation of data. All authors read and approved the final manuscript.
Categorical cumulative exposures, Camp Lejeune compared to Camp Pendleton (referent).
Click here for file
Categorical Cumulative Exposures and Underlying Cause of Death.
Click here for file
Cumulative Exposures and Underlying Cause of Death.
Click here for file
Splines of selected causes of death and cumulative exposures.
Click here for file
The authors would like to thank Dana Flanders and Kyle Steenland of Emory University, Rollins School of Public Health for their statistical advice in preparing this manuscript. The authors thank Walter M. Grayman and the members of the Camp Lejeune water modeling team: Robert E. Faye, Jason B. Sautner, René J. Suárez-Soto, Barbara A. Anderson, Mustafa M. Aral, Jinjun Wang, Wonyong Jang, Amy Krueger, Claudia Valenzuela, and Joseph W. Green, Jr. The authors would also like to thank Kerry Grace Morrissey, Sigurd Hermansen, Vanessa Olivo, and Tim McAdams of WESTAT for preparing the data for analyses.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry.